from May 28, 2020 to May 29, 2020
02:00 PM ET
Speaker(s):
-
Anthony Ting, Vice President, Regenerative Medicine, Head of CardioPulmonary Programs
- State of the Art: Success and Failure of Cell Therapy Clinical Trials for Acute and Chronic Lung Diseases - Dr. Ting will present "MultiStem for Acute Respiratory Distress Syndrome (MUST-ARDS study)"
- Dr. Ting will be the session chair for: Strategies for Commercialization PLENARY Session - Is Big Pharma Ready for Industrial Scale Cell and Gene Therapy?
- ISCT CSO Global Showcase on Covid-19, Part II 'A New Hope' - Dr. Ting will present "Industry-led Cell Therapy Clinical Trials for COVID-19"
http://www.isct2020.com/